AI
Thursday, January 15, 2009 7:14:02 PM
Maybe I have become completely discouraged by the lack of (positive) interest in the stock but I am beging to wonder how much of a splash the INFORM-1 will be. The way I see it if the viral load reductions aren't in the mid to high 5's it will be disappointing. Further more if there is any safety concern (because of the Pharmasset compound of course 
) people will be very disappointed. OK maybe a few scientists will get excited and some patients but maybe not investors
Am I missing something?
Perhaps if they give RVR data it will be more of a splash but they did not say they would do that. I am guessing because its only two weeks on drug and the only reason to say what it is if the numbers are comparable to what other Protease/Polymerases have done with SOC in longer treatment periods.
) people will be very disappointed. OK maybe a few scientists will get excited and some patients but maybe not investors Am I missing something?
Perhaps if they give RVR data it will be more of a splash but they did not say they would do that. I am guessing because its only two weeks on drug and the only reason to say what it is if the numbers are comparable to what other Protease/Polymerases have done with SOC in longer treatment periods.
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
